 |
Previous Article | Next Article 
The Journal of Neuroscience, January 1, 2002, 22(1):38-43
Interleukin-1 Influences Ischemic Brain Damage in the Mouse
Independently of the Interleukin-1 Type I Receptor
Omar
Touzani*, *,
Herve
Boutin*, *,
Rosalind
LeFeuvre,
Lisa
Parker,
Andy
Miller,
Giamal
Luheshi, and
Nancy
Rothwell
School of Biological Sciences, University of Manchester, M13 9PT,
United Kingdom
The cytokine interleukin-1 (IL-1 ) contributes to ischemic,
excitotoxic, and traumatic brain injury. IL-1 actions depend on
interaction with a single receptor (IL-1RI), which associates with an
accessory protein (IL-1RAcP), and is blocked by IL-1 receptor antagonist (IL-1ra). Here we show that in normal mice [wild-type (WT)], intracerebroventricular injection of IL-1ra markedly reduces ( 50%; p < 0.01) ischemic brain damage caused by
reversible occlusion of the middle cerebral artery, whereas injection
of IL-1 exacerbates damage (+45%; p < 0.05).
Mice lacking IL-1RI [IL-1RI knock-out (KO)] exhibited ischemic
brain damage that is almost identical to that of the WT (infarct volume
43.7 ± 6.1 and 46.2 ± 6.2 mm3,
respectively), but failed to respond to injection of IL-1ra. However,
injection of IL-1 (intracerebroventricularly) exacerbated ischemic
brain damage in IL-1RI KO (+61%; p < 0.001) and
in WT mice (+45%). This effect of IL-1 was abolished by heat
denaturation in all animals, and was reversed by IL-1ra in
WT, but not IL-1RI KO mice. In contrast, IL-1RI KO mice were completely
resistant to effects of IL-1 on food intake or body weight. IL-1RAcP
mRNA was increased by stroke in WT, but reduced in IL-1RI KO mice
compared with sham-operated mice. Type II IL-1 receptor mRNA was
significantly increased 4 hr after ischemia in WT and IL-1RI KO (+20%) animals.
These data show that IL-1 can exacerbate ischemic brain damage
independently of IL-1RI and suggest the existence of additional signaling receptor or receptors for IL-1 in the brain.
Key words:
cerebrovascular accident; brain infarction; receptors; interleukin-1; mice; knock-out; cytokines
*
O.T. and H.B. contributed equally to this work.
Correspondence should be addressed to Prof. Nancy Rothwell, School of
Biological Sciences, 1.124 Stopford Building, University of Manchester,
M13 9PT, UK. E-mail: Nancy.Rothwell{at}man.ac.uk.
O. Touzani's present address: Université de Caen-Unité
Mixte de Recherche Centre National de la Recherche Scientifique 6551, Centre Cyceron, Boulevard H. Becquerel BP 5229, 14074 Caen, France.
G. Luheshi's present address: The Douglas Hospital Research Center,
6875 Boulevard Lassale, Verdun, Quebec H4R 1R3, Canada.
Copyright © 2002 Society for Neuroscience 0270-6474/02/22138-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev,
January 1, 2008;
88(1):
211 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fogal, J. Li, D. Lobner, L. D. McCullough, and S. J. Hewett
System xc Activity and Astrocytes Are Necessary for Interleukin-1{beta}-Mediated Hypoxic Neuronal Injury
J. Neurosci.,
September 19, 2007;
27(38):
10094 - 10105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Struzynska, B. Dabrowska-Bouta, K. Koza, and G. Sulkowski
Inflammation-Like Glial Response in Lead-Exposed Immature Rat Brain
Toxicol. Sci.,
January 1, 2007;
95(1):
156 - 162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Samardzija, A. Wenzel, M. Thiersch, R. Frigg, C. Reme, and C. Grimm
Caspase-1 Ablation Protects Photoreceptors in a Model of Autosomal Dominant Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci.,
December 1, 2006;
47(12):
5181 - 5190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Honore, D. Donnelly-Roberts, M. T. Namovic, G. Hsieh, C. Z. Zhu, J. P. Mikusa, G. Hernandez, C. Zhong, D. M. Gauvin, P. Chandran, et al.
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1376 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lazovic, A. Basu, H.-W. Lin, R. P. Rothstein, J. K. Krady, M. B. Smith, and S. W. Levison
Neuroinflammation and Both Cytotoxic and Vasogenic Edema Are Reduced in Interleukin-1 Type 1 Receptor-Deficient Mice Conferring Neuroprotection
Stroke,
October 1, 2005;
36(10):
2226 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Lynch, M. Moore, S. Craig, P. E. Lonergan, D. S. Martin, and M. A. Lynch
Analysis of Interleukin-1{beta}-induced Cell Signaling Activation in Rat Hippocampus following Exposure to Gamma Irradiation: PROTECTIVE EFFECT OF EICOSAPENTAENOIC ACID
J. Biol. Chem.,
December 19, 2003;
278(51):
51075 - 51084.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|